Golden, CO
BioIntelliSense has enabled medical-grade Remote Patient Monitoring Hospital at Home (RPM-H@H) via its BioSticker-based data service. The BioSticker™ is an FDA-cleared 510k class II wearable medical device that enables at-home continuous monitoring of vital signs and symptoms directly associated with COVID-19 (temperature, respiratory rate at rest, and coughing frequency) for 30 days on a single device without recharging.
biointellisense.comThese are collections BioIntelliSense is a part of. Click on the collection name to view similar companies.
Series B
$45,000,000
Grant
$2,800,000
Series Unknown
$12,000,003
Series A
$24,997,665
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on BioIntelliSense.